Journals / Archives of epilepsy (Online) / 2022 / Cilt: 28 - Sayı: 1

Could Coronavirus Disease 2019 Vaccine Be a New Terminology in Epileptic Seizure Etiology?

Pages
43–45
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The patient whose seizure did not recur was discharged.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:An epileptic seizure is the clinical reflection of abnormal paroxysmal activities of neurons.
📊
Key Findings & Data:While the incidence of acute symptomatic seizures is 30-39/100 000, it is seen most frequently before the age of 20 and after the age of 60 with the second frequency.
💡
Conclusion & Impact:The patient whose seizure did not recur was discharged.
🔬Design:Research Article
📍Scope:2019 Verileri
⚙️Variables:Domain Parameters

Abstract

An epileptic seizure is the clinical reflection of abnormal paroxysmal activities of neurons. Its frequency varies according to age. While the incidence of acute symptomatic seizures is 30-39/100 000, it is seen most frequently before the age of 20 and after the age of 60 with the second frequency. Causes such as metabolic disorders, head trauma, and cerebrovascular disease may cause an acute symptomatic seizure. In inactivated coronavirus disease 2019 vaccines, side effects may develop due to inflammation of body cells against given foreign substances. In order to raise awareness, we presented our advanced age case who presented with epileptic seizure after the coronavirus disease 2019 vaccine. A 72-year-old female patient was brought to the emergency room because of convulsions and wheezing after fainting. It was learned that she had urinary incontinence and foaming at the mouth during contraction. She had a history of diabetes and hypertension. She had no previous history of epileptic seizures. It was learned she had a third dose of coronavirus disease 2019 vaccine 3 days ago. There was no feature in her family history. Her vitals, physical, and neurological examinations were normal. Blood tests, cardiac examinations, neuroimaging, and cerebrospinal fluid analysis were normal. Once an epileptic seizure was observed in the follow-up, antiepileptic therapy was started. The patient whose seizure did not recur was discharged.

🔖

Cite This Article

Durmuş, B., Özkaya, S. (2022). Could Coronavirus Disease 2019 Vaccine Be a New Terminology in Epileptic Seizure Etiology?. Archives of epilepsy (Online), Cilt: 28 - Sayı: 1, 43–45. https://ajindex.com/articles/447844

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (2)

  1. Catlett CL. Seizures and status epilepticus in adults. In: Tintinalli JE, Kelen GD, Stapczynski JS, eds. Emergency Medicine: A Comprehensive Study Guide. 6th ed. New York: McGraw-Hill; 2004:1409-1417
  2. Yapici-Eser H, Koroglu YE, Oztop-Cakmak O, Keskin O, Gursoy A, Gursoy-Ozdemir Y. Neuropsychiatric symptoms of COVID-19 explained by SARS-CoV-2 proteins’ mimicry of human protein interactions. Front Hum Neurosci. 2021;15:656313. [CrossRef] 3. Zhou F, Shefer A, Wenger J, et al. “Economic evaluation of the routine childhood immunization program in the United States, 2009.” pediatrics vol. Pediatrics. 2014;133(4):577-585. [CrossRef] 4. Tanriover MD, Doğanay HL, Akova M, et al. Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey. Lancet. 2021;398(10296):213-222. [CrossRef] 5. Zhang Y, Zeng G, Pan H, et al. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial. Lancet Infect Dis. 2021;21(2):181-192. [CrossRef] 6. Barda N, Dagan N. Safety of the BNT162b2 mRNA Covid-19 vaccine in a nationwide setting. N Engl J Med. 2021:1-13. [CrossRef] 7. Ghosh R, Dubey S, Roy D, Mandal A, Naga D, Benito-León J. Focal onset non-motor seizure following COVID-19 vaccination: a mere coin- cidence? Diabetes Metab Syndr. 2021;15(3):1023-1024. [CrossRef] 8. Umakanthan S, Chattu VK, Ranade AV, Das D, Basavarajegowda A, Bukelo M. A rapid review of recent advances in diagnosis, treatment and vaccination for COVID-19. AIMS Public Health. 2021;8(1):137-153. [CrossRef] 9. Acharya JN, Acharya VJ. Epilepsy in the elderly: special considerations and challenges. Ann Indian Acad Neurol. 2014;17(Suppl 1):S18-S26. [CrossRef] 10. So EL, Annegers JF, Hauser WA, O’Brien PC, Whisnant JP. Population- based study of seizure disorders after cerebral infarction. Neurology. 1996;46(2):350-355. [CrossRef] 11. Ng SK, Hauser WA, Brust JC, Susser M. Hypertension and the risk of new-onset unprovoked seizures. Neurology. 1993;43(2):425-428. [CrossRef]